None listed
Conditions
Interventions
Drug : After the patient arrives in the operating room, patient identity is confirmed and baseline vital signs are assessed. The prepared study medication is then administered intravenously according
Sponsors
Chonnam National University Hwasun Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with an American Society of Anesthesiologists Physical Status (ASA PS) classification of 1–3 2. Patients aged 20 to 79 scheduled for elective video-assisted thoracoscopic surgery under general anesthesia 3. Patients who have voluntarily provided written consent to participate in this clinical study
Exclusion criteria
Exclusion criteria: 1. Patients with hypersensitivity to Unafra 2. Patients with unstable angina or congestive heart failure; patients with ECG readings showing QRS > 200 msec, or QTcF > 450 msec (males) or QTcF > 470 msec (females) 3. Patients with moderate to severe renal impairment 4. Patients with moderate to severe hepatic impairment 5. Pregnant or lactating women 6. Patients receiving drugs known to prolong PR or QRS intervals 7. Patients receiving potent CYP3A4 inhibitors 8. Patients with physical disabilities or illiteracy 9. Patients otherwise deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Korean version of Quality of Recovery-40 score;Patient-controlled analgesia opioid consumption | — |
Secondary
| Measure | Time frame |
|---|---|
| Korean version of Quality of Recovery-40 score;Dose of Remifentanil used during surgery;Numeric Rating Scale;Postoperative Nausea and Vomiting score ;Patient-controlled analgesia opioid consumption | — |
Countries
Korea, Republic of
Contacts
Public ContactHyorim Jung
Chonnam National University Hwasun Hospital
Outcome results
None listed